The European Union, China, and Norway Wednesday joined UN Secretary General Antonio Guterres in decrying United States President Donald Trump’s decision to suspend US funding to the World Health Organization – at a critical moment in the international agency’s coordination of the global COVID-19 response. Trump announced Tuesday night that the US administration would suspend […] Continue reading ->
WHO Director General Dr. Tedros Adhanom Ghebreyesus said on Monday that the relationship between WHO and the United States is “very good” and that, despite the recent maelstrom of criticism by President Donald Trump over WHO’s handling of the COVID-19 crisis, he hoped that funding from the USA will continue.  “I hope the funding to […] Continue reading ->
While much of the public fanfare around new COVID-19 drugs has centered around the lupus drug, hydroxychloroquine, and a failed Ebola remedy, remdesivir, other researchers are keen to explore the potential of other time-worn remedies – although here, too, experts are urging extreme caution.    Ivermectin, the antiparasitic drug that turned the tide in the […] Continue reading ->
People with COVID-19 are dying at significantly higher rates in communities in the United States with higher air pollution levels, according to a new Harvard University study  – the first such study to systematically examine links between air pollution and higher COVID-19 mortality.  For every 1 microgram/ cubic meter (µg/m3) increase in average annual levels […] Continue reading ->
WHO deferred any broad recommendation to the public on the use of face masks, even as more countries were recommending some kind of a face cover or protective mask to reduce COVID-19 transmission. World Health Organization Director General Dr Tedros Adhanom Ghebreyesus stressed that health workers need to remain the key priority for the use […] Continue reading ->
The European Medicines Agency on Friday issued new guidance supporting the use of Gilead Sciences’ antiviral remdesivir as a COVID-19 treatment under compassionate use programmes. The new EMA guidelines on remdesivir recommend its compassionate use  in adult COVID-19 patients experiencing severe disease requiring invasive mechanical ventilation. Such compassionate use programmes are set up by individual […] Continue reading ->